Comparative cancer survival in European countries

Alastair J. Munro

    Research output: Contribution to journalArticle

    15 Citations (Scopus)

    Abstract

    Background
    Survival for patients with cancer varies widely across Europe. This review is an attempt to explore some of the factors that influence this variation.

    Sources of data
    The data on cancer survival come from EUROCARE-5 and a recent OECD report. These figures have been analysed together with data from a variety of other sources: other OECD data sets; EUROSTAT; The World Bank; Gallup and the World Health Organisation.

    Areas of agreement
    This study confirms the importance of national socio-economic factors in influencing the outcomes for patients with cancer.

    Areas of controversy
    The usual suspects (limited access to expensive new cancer drugs; delayed diagnosis and late presentation) may have less influence on cancer survival than is usually assumed.

    Growing points
    Disparities in outcomes challenge systems of health care to re-evaluate their strategies. The key point is that these new strategies need to be informed by facts, rather than suppositions.

    Areas timely for developing research
    The role and scope of national cancer registries should be enhanced. We need to record more detailed information on each patient with cancer and, in an era of linked data, cancer registries are ideally placed to collect and curate such information.
    Original languageEnglish
    Pages (from-to)5-22
    Number of pages18
    JournalBritish Medical Bulletin
    Volume110
    Issue number1
    DOIs
    Publication statusPublished - Jun 2014

    Fingerprint

    Survival
    Neoplasms
    Registries
    United Nations
    Information Storage and Retrieval
    Delayed Diagnosis
    Economics
    Delivery of Health Care
    Pharmaceutical Preparations
    Organisation for Economic Co-Operation and Development

    Cite this

    Munro, Alastair J. / Comparative cancer survival in European countries. In: British Medical Bulletin. 2014 ; Vol. 110, No. 1. pp. 5-22.
    @article{5668f83c7c19475683e7a9748372cd33,
    title = "Comparative cancer survival in European countries",
    abstract = "BackgroundSurvival for patients with cancer varies widely across Europe. This review is an attempt to explore some of the factors that influence this variation.Sources of dataThe data on cancer survival come from EUROCARE-5 and a recent OECD report. These figures have been analysed together with data from a variety of other sources: other OECD data sets; EUROSTAT; The World Bank; Gallup and the World Health Organisation.Areas of agreementThis study confirms the importance of national socio-economic factors in influencing the outcomes for patients with cancer.Areas of controversyThe usual suspects (limited access to expensive new cancer drugs; delayed diagnosis and late presentation) may have less influence on cancer survival than is usually assumed.Growing pointsDisparities in outcomes challenge systems of health care to re-evaluate their strategies. The key point is that these new strategies need to be informed by facts, rather than suppositions.Areas timely for developing researchThe role and scope of national cancer registries should be enhanced. We need to record more detailed information on each patient with cancer and, in an era of linked data, cancer registries are ideally placed to collect and curate such information.",
    author = "Munro, {Alastair J.}",
    year = "2014",
    month = "6",
    doi = "10.1093/bmb/ldu009",
    language = "English",
    volume = "110",
    pages = "5--22",
    journal = "British Medical Bulletin",
    issn = "0007-1420",
    publisher = "Oxford University Press",
    number = "1",

    }

    Comparative cancer survival in European countries. / Munro, Alastair J.

    In: British Medical Bulletin, Vol. 110, No. 1, 06.2014, p. 5-22.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Comparative cancer survival in European countries

    AU - Munro, Alastair J.

    PY - 2014/6

    Y1 - 2014/6

    N2 - BackgroundSurvival for patients with cancer varies widely across Europe. This review is an attempt to explore some of the factors that influence this variation.Sources of dataThe data on cancer survival come from EUROCARE-5 and a recent OECD report. These figures have been analysed together with data from a variety of other sources: other OECD data sets; EUROSTAT; The World Bank; Gallup and the World Health Organisation.Areas of agreementThis study confirms the importance of national socio-economic factors in influencing the outcomes for patients with cancer.Areas of controversyThe usual suspects (limited access to expensive new cancer drugs; delayed diagnosis and late presentation) may have less influence on cancer survival than is usually assumed.Growing pointsDisparities in outcomes challenge systems of health care to re-evaluate their strategies. The key point is that these new strategies need to be informed by facts, rather than suppositions.Areas timely for developing researchThe role and scope of national cancer registries should be enhanced. We need to record more detailed information on each patient with cancer and, in an era of linked data, cancer registries are ideally placed to collect and curate such information.

    AB - BackgroundSurvival for patients with cancer varies widely across Europe. This review is an attempt to explore some of the factors that influence this variation.Sources of dataThe data on cancer survival come from EUROCARE-5 and a recent OECD report. These figures have been analysed together with data from a variety of other sources: other OECD data sets; EUROSTAT; The World Bank; Gallup and the World Health Organisation.Areas of agreementThis study confirms the importance of national socio-economic factors in influencing the outcomes for patients with cancer.Areas of controversyThe usual suspects (limited access to expensive new cancer drugs; delayed diagnosis and late presentation) may have less influence on cancer survival than is usually assumed.Growing pointsDisparities in outcomes challenge systems of health care to re-evaluate their strategies. The key point is that these new strategies need to be informed by facts, rather than suppositions.Areas timely for developing researchThe role and scope of national cancer registries should be enhanced. We need to record more detailed information on each patient with cancer and, in an era of linked data, cancer registries are ideally placed to collect and curate such information.

    UR - http://www.scopus.com/inward/record.url?scp=84902009383&partnerID=8YFLogxK

    U2 - 10.1093/bmb/ldu009

    DO - 10.1093/bmb/ldu009

    M3 - Article

    VL - 110

    SP - 5

    EP - 22

    JO - British Medical Bulletin

    JF - British Medical Bulletin

    SN - 0007-1420

    IS - 1

    ER -